Immunohistochemical study of 49 cutaneous melanomas: p53, PCNA, Bcl-2 expression and multidrug resistance

被引:13
作者
Loggini, B
Rinaldi, I
Pingitore, R
Cristofani, R
Castagna, M
Barachini, P
机构
[1] Univ Pisa, Dept Expt Pathol, Pathol Lab, Dept Surg, I-56100 Pisa, Italy
[2] Univ Pisa, Epidemiol Sect, I-56100 Pisa, Italy
[3] Univ Pisa, Dermatol Sect, I-56100 Pisa, Italy
关键词
melanoma; tumor markers; prognosis;
D O I
10.1177/030089160108700313
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims and background: Thickness and level of invasion are the main morphological elements for an approximate but not sufficiently sensitive prognostic evaluation of cutaneous melanomas. By using immunohistochemical methods it is possible to detect biological markers related to prognosis. We have studied p53, PCNA, Bcl-2 and P-gp expression in 49 primary cutaneous melanomas. Materials: We used the immunophosphatase APAAP immuno-histochemical method. The percentage of labeled cells (according to four classes of positivity: <5%; 5-25%; 25-50%; > 50%) and the localization of immunoreactivity were expressed for each marker. Statistical analysis was performed to determine the correlations between markers and level or thickness of melanomas. Results: We found a good correlation between p53 expression and melanoma thickness (P <0.005), PCNA and P-gp expression. No relationship was observed between Bcl-2 expression and the different variables considered or other markers. Conclusions: Our data seem to indicate an unfavorable prognostic role of higher nuclear p53 expression. However, we believe that our results need to be integrated with patients' clinical follow-up and with the study of the expression of these markers in benign melanocytic lesions to gain more accurate information about their prognostic significance.
引用
收藏
页码:179 / 186
页数:8
相关论文
共 31 条
[1]   INTRINSIC MDR-1 GENE AND P-GLYCOPROTEIN EXPRESSION IN HUMAN-MELANOMA CELL-LINES [J].
BERGER, W ;
ELBLING, L ;
MINAIPOUR, M ;
VETTERLEIN, M ;
PIRKER, R ;
KOKOSCHKA, EM ;
MICKSCHE, M .
INTERNATIONAL JOURNAL OF CANCER, 1994, 59 (05) :717-723
[2]  
BJORNHAGEN V, 1994, AM J DERMATOPATH, V16, P615
[3]   CYCLIN PCNA IS THE AUXILIARY PROTEIN OF DNA POLYMERASE-DELTA [J].
BRAVO, R ;
FRANK, R ;
BLUNDELL, PA ;
MACDONALDBRAVO, H .
NATURE, 1987, 326 (6112) :515-517
[4]   BCL-2 PROTEIN EXPRESSION IN CUTANEOUS MALIGNANT-MELANOMA AND BENIGN MELANOCYTIC NEVI [J].
CERRONI, L ;
SOYER, HP ;
KERL, H .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1995, 17 (01) :7-11
[5]  
CIANFRIGLIA M, 1994, INT J CANCER, V56, P153
[6]   INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) AND BCL-2 ARE DIFFERENTIALLY EXPRESSED IN EARLY EVOLVING MALIGNANT-MELANOMA [J].
COLLINS, KA ;
WHITE, WL .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1995, 17 (05) :429-438
[7]   EXPRESSION OF THE MULTIDRUG RESISTANCE GENE-PRODUCT (P-GLYCOPROTEIN) IN HUMAN NORMAL AND TUMOR-TISSUES [J].
CORDONCARDO, C ;
OBRIEN, JP ;
BOCCIA, J ;
CASALS, D ;
BERTINO, JR ;
MELAMED, MR .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1990, 38 (09) :1277-1287
[8]   P53 PROTEIN EXPRESSION IN NEVI AND MELANOMAS [J].
CRISTOFOLINI, M ;
BOI, S ;
GIRLANDO, S ;
ZUMIANI, G ;
CRISTOFOLINI, P ;
PALMA, PD ;
DOGLIONI, C ;
BARBARESCHI, M .
ARCHIVES OF DERMATOLOGY, 1993, 129 (06) :739-743
[9]   P-GLYCOPROTEIN EXPRESSION IN MALIGNANT-MELANOMA [J].
FUCHS, B ;
OSTMEIER, H ;
SUTER, L .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1991, 117 (02) :168-171
[10]   IMMUNOHISTOCHEMICAL LOCALIZATION OF PROLIFERATING CELL NUCLEAR ANTIGEN CYCLIN IN HUMAN SKIN [J].
FURUKAWA, F ;
IMAMURA, S ;
FUJITA, M ;
KINOSHITA, K ;
YOSHITAKE, K ;
BROWN, WR ;
NORRIS, DA .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1992, 284 (02) :86-91